コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and in the use of a prolonged incubation for Burkholderia cepacia.
2 is and other species, including (cultivable) Burkholderia cepacia.
3 bors, such as Burkholderia thailandensis and Burkholderia cepacia.
4 oteobacteria including a clinical isolate of Burkholderia cepacia.
5 ise bacteria previously identified merely as Burkholderia cepacia.
6 and an internal fragment of an NRAMP gene in Burkholderia cepacia.
12 ont Rhizobium NGR234 and the root-colonizing Burkholderia cepacia AMMD, conferred to Escherichia coli
13 cretion genes in the gram-negative bacterium Burkholderia cepacia, an important pulmonary pathogen in
14 MN(+) mice survived after being administered Burkholderia cepacia, an opportunistic pathogen in CGD p
15 ese reactive species in host defense against Burkholderia cepacia and Chromobacterium violaceum, orga
17 gative pathogens, including Yersinia pestis, Burkholderia cepacia, and Acinetobacter haemolyticus, sy
19 s of IS285 from Yersinia pestis, IS1356 from Burkholderia cepacia, and ISRm3 from Rhizobium meliloti.
20 late isolates of Pseudomonas aeruginosa and Burkholderia cepacia are associated with differences in
24 ueous Pb(II) sorbed at the interface between Burkholderia cepacia biofilms and hematite (alpha-Fe(2)O
25 during apoptosis induced by phagocytosis of Burkholderia cepacia, Borrelia hermsii, Listeria monocyt
26 spp., Ralstonia spp., Burkholderia gladioli, Burkholderia cepacia, Burkholderia thailandensis, and Ps
28 rbaspirillum species can be misidentified as Burkholderia cepacia by commercially available microbial
29 n the pathogenesis of respiratory disease in Burkholderia cepacia-colonized cystic fibrosis (CF) pati
30 ost described the use of selective media for Burkholderia cepacia complex (99%), Staphylococcus aureu
40 oacae, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex (BCC) may be able to produc
41 undred thirty-eight clinical isolates of the Burkholderia cepacia complex (Bcc) were identified using
42 terization of the opportunistic pathogens of Burkholderia cepacia complex (BCC), a group composed of
47 initive identification of the species in the Burkholderia cepacia complex by routine clinical microbi
50 fe threatening infection with species of the Burkholderia cepacia complex frequently occurs as a resu
51 or the rapid detection and identification of Burkholderia cepacia complex genomovars directly from sp
53 t pathogens that account for the majority of Burkholderia cepacia complex infections in cystic fibros
56 r relative levels of accuracy in identifying Burkholderia cepacia complex isolates recovered from cys
58 PCR primers targeting loci in the current Burkholderia cepacia complex multilocus sequence typing
59 Pseudomonas aeruginosa and members of the Burkholderia cepacia complex often coexist in both the s
61 thods is difficult, and differentiation from Burkholderia cepacia complex organisms may be especially
64 rosis (CF) patients including members of the Burkholderia cepacia complex that cause a high rate of m
65 ted from biofilms produced by species of the Burkholderia cepacia complex were shown to possess clust
67 ia cenocepacia is an important member of the Burkholderia cepacia complex, a group of closely related
68 s species and closely related species in the Burkholderia cepacia complex, accurate identification is
69 elective media designed for the isolation of Burkholderia cepacia complex, along with two media desig
71 epacia strain K56-2, a representative of the Burkholderia cepacia complex, is part of the epidemic an
72 Gram-negative bacterium and a member of the Burkholderia cepacia complex, which is frequently associ
81 We investigated the utility of PCR to detect Burkholderia cepacia directly in sputum samples at two c
82 more active than other tetracyclines against Burkholderia cepacia, Escherichia coli, Serratia marcesc
83 on of the related toluene o-monooxygenase of Burkholderia cepacia G4 and a previously reported T4MO G
84 vity of toluene ortho-monooxygenase (TOM) of Burkholderia cepacia G4 for both chlorinated ethenes and
85 ion and toluene ortho-monooxygenase (TOM) of Burkholderia cepacia G4 hydroxylates at the ortho positi
87 alyzed a collection of 97 well-characterized Burkholderia cepacia genomovar III isolates to evaluate
100 egorize patients into panresistant (n = 27) (Burkholderia cepacia, n = 6, and Pseudomonas aeruginosa,
103 ied within a 27-kb region of DNA cloned from Burkholderia cepacia R34, a strain that grows using 2,4-
104 oblematic, and analysis of isolates from the Burkholderia cepacia Research Laboratory and Repository
105 ng a panel of 102 isolates obtained from the Burkholderia cepacia Research Laboratory and Repository.
106 ferredoxins (the Thermus Rieske protein, the Burkholderia cepacia Rieske-type biphenyl dioxygenase fe
107 veral clinical and environmental isolates of Burkholderia cepacia secreted ATP-utilizing enzymes to t
108 m of this study was to compare RGM medium to Burkholderia cepacia selective agar (BCSA) and a standar
109 ients with CF by extending incubation of the Burkholderia cepacia selective agar (BCSA) from 5 to 14
113 dation of tryptophan through anthranilate by Burkholderia cepacia, several plasposon mutations were c
114 ung disease including Staphylococcal aureus, Burkholderia cepacia, Stenotrophomonas maltophilia, Achr
115 led tobramycin did not increase isolation of Burkholderia cepacia, Stenotrophomonas maltophilia, or A
116 y reviewing isolates initially identified as Burkholderia cepacia susceptible to all antibiotics test
119 rgillus fumigatus, Staphylococcus aureus, or Burkholderia cepacia were compared in wild-type, X-CGD m
121 incubated with P. aeruginosa strain PAK and Burkholderia cepacia, while little activation was observ
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。